NETSPOT INJECTION HOW TO

“Netspot provides another diagnostic tool whose results will help clinicians determine the location and extent of the tumor. What Is Netspot Netspot (kit for the preparation of gallium Ga 68 dotatate injection), after radiolabeling with Ga 68, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients. “Use of advanced imaging techniques to detect rare neuroendocrine tumors at an early stage in patients is critical,” Libero Marzella, MD, PhD, director of the Division of Medical Imaging Products in the FDA’s Center for Drug Evaluation and Research, said in a press release. The studies reported no serious adverse reactions. The FDA based its approval on positive safety and efficacy results from three studies - the first compared Ga 68 dotatate images of neuroendocrine tumors to images obtained with an approved drug, which were then confirmed with CT or MRI the second study evaluated Ga 68 dotatate images using histopathology or clinical follow-up and the third study evaluated patients with neuroendocrine tumor recurrence using Ga 68 dotatate images. Answer: Please Login as a SNMMI Member to access the answers to the Coding and Reimbursement Q&As.

NETSPOT INJECTION HOW TO

You will receive an injection of a radiopharmaceutical, which is completely safe. Could you please tell us how to code the FDA-approved (June 2, 2016) radiopharmaceutical Ga-68 labeled DOTATATE, injection (NETSPOT), a PET imaging agent for localization of somatostatin receptor-positive neuroendocrine tumors (NETs).

Netspot (Advanced Accelerator Applications USA) - a sterile, single-dose kit for the preparation of gallium Ga 68 dotatate intravenous injection, a radioactive diagnostic agent for PET imaging - is indicated to help locate tumors in adult and pediatric patients with somatostatin receptor positive neuroendocrine tumors. NETSPOT - GALLIUM 68 DOTATE PET/CT Prep Sheet. The FDA approved the diagnostic imaging agent Netspot to detect rare neuroendocrine tumors. If you continue to have this issue please contact to Healio

Netspot injection